Close Menu

NEW YORK (GenomeWeb) – The National Comprehensive Cancer Network has updated its guidelines on early detection of prostate cancer to include more specific language about how often men with BRCA mutations should be screened and the potential utility of certain biomarkers for determining high-grade cancer risk.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.